BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

HAPTO Biotech Ltd. 

Ein Kerem Medical Center
P.O.Box: 1200
Jerusalem    91120  Israel
Phone: 02-6778757 Fax: 02-6437712


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





 Company News
Ortec International Inc. (ORTN.OB) Completes Merger With HAPTO Biotech Ltd. 4/17/2006 12:09:31 PM    More...
Ortec International Inc. (ORTN.OB) Announces $6.16 Million Private Placement Paving Way For Merger With HAPTO Biotech Ltd. 4/5/2006 10:22:26 AM    More...
Ortec International Inc. (ORTN.OB) Expands Focus To Stem Cell and Regenerative Medicine With Announcement Of Letter Of Intent To Acquire HAPTO Biotech Ltd.'s Fibrin And Peptide Stem Cell And Cell Attachment Technologies 12/15/2005 2:32:43 PM    More...
Ortec International And HAPTO Biotech Ltd. Form Joint Venture To Pursue Advanced Peptide Based Biomaterial Product For Wound Healing And Tissue Regeneration 10/19/2005 5:11:47 PM    More...
Ortec International Inc. (ORTN.OB) And HAPTO Biotech Ltd. Announce Positive Results With Biologically Active Biomaterial Applicable To Cosmetic Tissue Augmentation And Wound Healing Markets 10/19/2005 5:09:51 PM    More...
OXIS International, Inc. (OXIS) Licenses Lead Compound To HaptoGuard Inc.; BXT-51072, Phase II Compound, To Be Developed For Cardiovascular Diseases 10/19/2005 5:09:18 PM    More...

//-->